These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 20361363

  • 21. Clinical management of neuroleptic malignant syndrome.
    Susman VL.
    Psychiatr Q; 2001; 72(4):325-36. PubMed ID: 11525080
    [Abstract] [Full Text] [Related]

  • 22. Exacerbating factors in neuroleptic malignant syndrome: comparisons between cases with death, sequelae, and full recovery.
    Nagamine M, Yoshino A, Sakurai Y, Sanga M, Takahashi R, Nomura S.
    J Clin Psychopharmacol; 2005 Oct; 25(5):499-501. PubMed ID: 16160631
    [No Abstract] [Full Text] [Related]

  • 23. Suspected neuroleptic malignant syndrome in a patient receiving clozapine.
    Ganelin L, Lichtenberg PS, Marcus EL, Munter RG.
    Ann Pharmacother; 1996 Mar; 30(3):248-50. PubMed ID: 8833560
    [Abstract] [Full Text] [Related]

  • 24. Assessing treatment of neuroleptic malignant syndrome.
    Susman VL, Addonizio G.
    Am J Psychiatry; 1986 Jan; 143(1):120-1. PubMed ID: 3942270
    [No Abstract] [Full Text] [Related]

  • 25. [Beneficial effect of bromocriptine in a patient with malignant syndrome and hepatic dysfunctions].
    Onaka A, Aibiki M, Shirakawa Y, Chikano S, Yokono S, Ogli K.
    Masui; 1993 Mar; 42(3):431-4. PubMed ID: 8468790
    [Abstract] [Full Text] [Related]

  • 26. Neuroleptic malignant syndrome improved by bromocriptine.
    Misra A.
    J Assoc Physicians India; 1991 Apr; 39(4):364. PubMed ID: 1938840
    [No Abstract] [Full Text] [Related]

  • 27. Current concepts. Neuroleptic malignant syndrome.
    Guzé BH, Baxter LR.
    N Engl J Med; 1985 Jul 18; 313(3):163-6. PubMed ID: 3892294
    [No Abstract] [Full Text] [Related]

  • 28. [Malignant hyperthermia susceptibility in 3 patients with malignant neuroleptic syndrome].
    Silva HC, Bahia VS, Oliveira RA, Marchiori PE, Scaff M, Tsanaclis AM.
    Arq Neuropsiquiatr; 2000 Sep 18; 58(3A):713-9. PubMed ID: 10973114
    [Abstract] [Full Text] [Related]

  • 29. [Malignant neuroleptic syndrome treated with bromocriptine].
    Fernández Ballesteros A, Cervero Jiménez M, Marco Martínez J, Martín Joven A.
    Rev Clin Esp; 1993 Jan 18; 192(1):49. PubMed ID: 8465032
    [No Abstract] [Full Text] [Related]

  • 30. Neuroleptic malignant syndrome: case report in a multiple trauma patient.
    Hirst R, Galloway GQ, Borzotta AP.
    Injury; 1993 Mar 18; 24(3):193-4. PubMed ID: 8509195
    [No Abstract] [Full Text] [Related]

  • 31. Concomitant treatment of neuroleptic malignant syndrome and psychosis.
    Goldwasser HD, Hooper JF, Spears NM.
    Br J Psychiatry; 1989 Jan 18; 154():102-4. PubMed ID: 2775937
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Neuroleptic malignant syndrome.
    Rampertaap MP.
    South Med J; 1986 Mar 18; 79(3):331-6. PubMed ID: 3513330
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Neuroleptic malignant syndrome and related conditions].
    Amore M, Montanari M.
    Minerva Psichiatr; 1992 Mar 18; 33(4):259-83. PubMed ID: 1363674
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Neuroleptic malignant syndrome.
    Larner AJ.
    Br J Psychiatry; 1992 Jun 18; 160():868. PubMed ID: 1617375
    [No Abstract] [Full Text] [Related]

  • 38. Neuroleptic malignant syndrome.
    Levenson JL.
    Am J Psychiatry; 1985 Oct 18; 142(10):1137-45. PubMed ID: 2863986
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Malignant neuroleptic syndrome: successful treatment of a patient with bromocriptine].
    Verhoeven WM, Elderson A.
    Ned Tijdschr Geneeskd; 1985 Jan 12; 129(2):76-8. PubMed ID: 3969176
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.